Literature DB >> 33423129

Higher midlife CAIDE score is associated with increased brain atrophy in a cohort of cognitively healthy middle-aged individuals.

Xulin Liu1, Maria-Eleni Dounavi2, Karen Ritchie3,4, Katie Wells5, Craig W Ritchie3, Li Su1, Graciela Muniz-Terrera3, John T O'Brien1.   

Abstract

BACKGROUND: Structural brain changes associated with Alzheimer's disease (AD) can occur decades before the onset of symptoms. The Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) score has been suggested to be associated with accelerated brain atrophy in middle-aged subjects but the regional specificity of atrophic areas remains to be elucidated.
METHODS: 3T T1-weighted magnetic resonance imaging scans of 160 cognitively healthy middle-aged participants (mean age = 52) in the PREVENT-Dementia cohort, from baseline and from follow-up after 2 years, were examined. Images were preprocessed using Computational Anatomy Toolbox 12. Voxel-based morphometry was performed in FSL 6.0.1 to identify areas of grey matter (GM) volume differences both cross-sectionally and longitudinally between subjects with high and low baseline CAIDE score (CAIDE score was dichotomized at cohort-median). A GM percentage of change map was created for each subject for evaluation of atrophy over 2 years. Analyses were adjusted for age, gender, education and total intracranial volume.
RESULTS: Compared to subjects with CAIDE score ≤ 6 (low risk), subjects with CAIDE score > 6 (high risk) showed lower GM volume in the temporal, occipital, and fusiform cortex and lingual gyrus at baseline, and greater percentage of GM loss over 2 years in the supramarginal gyrus, angular gyrus, precuneus, lateral occipital cortex, superior parietal lobule and cingulate gyrus (corrected P < 0.05).
CONCLUSION: This study demonstrated accelerated GM atrophy concentrated in several AD signature cortical regions in healthy middle-aged subjects with high CAIDE scores.

Entities:  

Keywords:  Alzheimer’s disease; Atrophy; Dementia; Grey matter; Middle aged

Year:  2021        PMID: 33423129     DOI: 10.1007/s00415-020-10383-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

Authors:  T G Ohm; H Müller; H Braak; J Bohl
Journal:  Neuroscience       Date:  1995-01       Impact factor: 3.590

Review 4.  The projected effect of risk factor reduction on Alzheimer's disease prevalence.

Authors:  Deborah E Barnes; Kristine Yaffe
Journal:  Lancet Neurol       Date:  2011-07-19       Impact factor: 44.182

5.  Frequency of stages of Alzheimer-related lesions in different age categories.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

6.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

7.  Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.

Authors:  E M Reiman; A Uecker; R J Caselli; S Lewis; D Bandy; M J de Leon; S De Santi; A Convit; D Osborne; A Weaver; S N Thibodeau
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

8.  Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.

Authors:  Lisa Mosconi; Michelle Walters; Joanna Sterling; Crystal Quinn; Pauline McHugh; Randolph E Andrews; Dawn C Matthews; Christine Ganzer; Ricardo S Osorio; Richard S Isaacson; Mony J De Leon; Antonio Convit
Journal:  BMJ Open       Date:  2018-03-23       Impact factor: 2.692

9.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

Authors:  Sam Norton; Fiona E Matthews; Deborah E Barnes; Kristine Yaffe; Carol Brayne
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

10.  Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.

Authors:  Ruth Stephen; Yawu Liu; Tiia Ngandu; Juha O Rinne; Nina Kemppainen; Riitta Parkkola; Tiina Laatikainen; Teemu Paajanen; Tuomo Hänninen; Timo Strandberg; Riitta Antikainen; Jaakko Tuomilehto; Sirkka Keinänen Kiukaanniemi; Ritva Vanninen; Seppo Helisalmi; Esko Levälahti; Miia Kivipelto; Hilkka Soininen; Alina Solomon
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more
  2 in total

1.  Fluid-attenuated inversion recovery magnetic resonance imaging textural features as sensitive markers of white matter damage in midlife adults.

Authors:  Maria-Eleni Dounavi; Audrey Low; Graciela Muniz-Terrera; Karen Ritchie; Craig W Ritchie; Li Su; Hugh S Markus; John T O'Brien
Journal:  Brain Commun       Date:  2022-05-05

2.  Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.

Authors:  Maria-Eleni Dounavi; Coco Newton; Natalie Jenkins; Elijah Mak; Audrey Low; Graciela Muniz-Terrera; Guy B Williams; Brian Lawlor; Lorina Naci; Paresh Malhotra; Clare E Mackay; Ivan Koychev; Karen Ritchie; Craig W Ritchie; Li Su; John T O'Brien
Journal:  J Neurol       Date:  2022-03-13       Impact factor: 6.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.